Cargando…

STAT5 is Expressed in CD34(+)/CD38(−) Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms

Janus kinase 2 (JAK2) and signal transducer and activator of transcription-5 (STAT5) play a key role in the pathogenesis of myeloproliferative neoplasms (MPN). In most patients, JAK2 V617F or CALR mutations are found and lead to activation of various downstream signaling cascades and molecules, incl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hadzijusufovic, Emir, Keller, Alexandra, Berger, Daniela, Greiner, Georg, Wingelhofer, Bettina, Witzeneder, Nadine, Ivanov, Daniel, Pecnard, Emmanuel, Nivarthi, Harini, Schur, Florian K. M., Filik, Yüksel, Kornauth, Christoph, Neubauer, Heidi A., Müllauer, Leonhard, Tin, Gary, Park, Jisung, de Araujo, Elvin D., Gunning, Patrick T., Hoermann, Gregor, Gouilleux, Fabrice, Kralovics, Robert, Moriggl, Richard, Valent, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225958/ https://www.ncbi.nlm.nih.gov/pubmed/32326377 http://dx.doi.org/10.3390/cancers12041021

Ejemplares similares

Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas
por: Orlova, Anna, et al.
Publicado: (2017)

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms
por: Hoermann, Gregor, et al.
Publicado: (2015)

Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis
por: Greiner, Georg, et al.
Publicado: (2020)

Engraftment in NSG(SCF) mice correlates with the WHO category and prognosis in systemic mastocytosis
por: Willmann, Michael, et al.
Publicado: (2023)

TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML
por: Valent, Peter, et al.
Publicado: (2017)

Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
por: Wingelhofer, Bettina, et al.
Publicado: (2018)

Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD(+) Acute Myeloid Leukemia
por: Bregante, Javier, et al.
Publicado: (2021)

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia
por: Maurer, Barbara, et al.
Publicado: (2020)

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
por: Peter, Barbara, et al.
Publicado: (2017)

Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin
por: Li, Geqiang, et al.
Publicado: (2010)

Genetic basis and molecular profiling in myeloproliferative neoplasms
por: Luque Paz, Damien, et al.
Publicado: (2023)

O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies
por: Freund, P, et al.
Publicado: (2017)

Identification of bromodomain-containing protein 4 (BRD4) as a novel marker and epigenetic target in mast cell leukemia
por: Wedeh, Ghaith, et al.
Publicado: (2015)

Pharmacologic inhibition of STAT5 in acute myeloid leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2018)

Incidence of symptomatic Covid‐19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population
por: Graf, Irene, et al.
Publicado: (2022)

Chloroquine inhibits human CD4(+) T-cell activation by AP-1 signaling modulation
por: Schmidt, Ralf L. J., et al.
Publicado: (2017)

In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells
por: Gamperl, Susanne, et al.
Publicado: (2020)

Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses
por: Bourgeais, Jerome, et al.
Publicado: (2016)

Circulating CD133+/–CD34– Have Increased c-MYC Expression in Myeloproliferative Neoplasms
por: Uslu Bıçak, İldeniz, et al.
Publicado: (2023)

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V(+) Neoplastic Mast Cells
por: Schneeweiss-Gleixner, Mathias, et al.
Publicado: (2022)

Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
por: Pecquet, Christian, et al.
Publicado: (2023)

Targeting STAT3 and STAT5 in Cancer
por: de Araujo, Elvin D., et al.
Publicado: (2020)

Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology
por: Hoermann, Gregor, et al.
Publicado: (2020)

Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
por: Blatt, Katharina, et al.
Publicado: (2018)

Gene expression profiling of CD34(+) cells from patients with myeloproliferative neoplasms
por: Sharma, Mugdha, et al.
Publicado: (2021)

Tracking fibrosis in myeloproliferative neoplasms by CCR2 expression on CD34(+) cells
por: Pozzi, Giulia, et al.
Publicado: (2022)

The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth
por: Nivarthi, Harini, et al.
Publicado: (2016)

Correction: The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth
por: Nivarthi, Harini, et al.
Publicado: (2018)

Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells
por: Gamperl, Susanne, et al.
Publicado: (2019)

Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms
por: Jäger, Roland, et al.
Publicado: (2014)

Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision Medicine
por: Heinemann, Tim, et al.
Publicado: (2022)

The PI3-Kinase/mTOR-Targeting Drug NVP-BEZ235 Inhibits Growth and IgE-Dependent Activation of Human Mast Cells and Basophils
por: Blatt, Katharina, et al.
Publicado: (2012)

FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H()
por: Valent, Peter, et al.
Publicado: (2013)

Next generation sequencing: clinical applications in solid tumours
por: Müllauer, Leonhard
Publicado: (2017)

Milestones in pathology—from histology to molecular biology
por: Müllauer, Leonhard
Publicado: (2017)

Molecular Pathology of Cancer: The Past, the Present, and the Future
por: Müllauer, Leonhard
Publicado: (2021)

Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
por: Gleixner, Karoline V., et al.
Publicado: (2017)

PB2476: TARGETING OF BRD4 TO COUNTERACT CYTOKINE-INDUCED EXPRESSION OF PD-L1 AND PD-L2 ON VASCULAR, OSTEOBLASTIC AND STROMAL NICHE CELLS
por: Filik, Yüksel, et al.
Publicado: (2023)

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis
por: Schneeweiss, Mathias, et al.
Publicado: (2018)

JAK‐STAT core cancer pathway: An integrative cancer interactome analysis
por: Erdogan, Fettah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bv6jbrn8g4snpntg799nvsqb96